Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Mar;71(3):2023–2030. doi: 10.1128/jvi.71.3.2023-2030.1997

Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution?

V V Lukashov 1, J Goudsmit 1
PMCID: PMC191287  PMID: 9032334

Abstract

We and others have shown that in individual human immunodeficiency virus type 1 (HIV-1) infection, the adaptive evolution of HIV-1 is influenced by host immune competence. In this study, we tested the hypothesis that in addition to selective forces operating within the host, transmission bottlenecks have an impact on HIV-1 intrahost evolution. Therefore, we studied the intrahost evolution of the V3 region of the external glycoprotein gp120 of HIV-1 during the 3- and 5-year periods following seroconversion after parenteral versus sexual (male-to-male) transmission in 41 participants of the Amsterdam prospective cohorts of homosexual men (n = 31) and intravenous drug users (IVDUs; n = 10) who were AIDS free and had comparable numbers of CD4+ cells. We observed that HIV-1 strains in homosexual men accumulated over 5 years more nonsynonymous substitutions within the V3 loop than HIV-1 strains in IVDUs as a result of lower rates of nonsynonymous evolution in both the initial 3-year period from seroconversion and the following 2-year period as well as a larger proportion of nonsynonymous back substitutions in IVDUs. The mean numbers of synonymous substitutions did not differ between the two risk groups. Since HIV-1 strains in IVDUs could be distinguished from the viruses of homosexual men based on several nucleotide substitutions of which the most conserved is a synonymous substitution at the tip of the V3 loop (GGC pattern), we studied whether the founder virus population itself has an impact on the intrahost evolution of HIV-1. The mean number of nonsynonymous substitutions accumulated over 5 years within the V3 loop was lower in 10 IVDUs infected by the HIV-1 strains with the GGC signature than in 4 IVDUs infected by HIV-1 strains lacking this pattern, while the mean numbers of synonymous substitutions were similar in the two groups.

Full Text

The Full Text of this article is available as a PDF (132.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams W. H., Rufo R. A., Talarico L., Silverman S. L., Brauer M. J. Thrombocytopenia and intravenous heroin use. Ann Intern Med. 1978 Aug;89(2):207–211. doi: 10.7326/0003-4819-89-2-207. [DOI] [PubMed] [Google Scholar]
  2. Barnett S. W., Barboza A., Wilcox C. M., Forsmark C. E., Levy J. A. Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals. Virology. 1991 Jun;182(2):802–809. doi: 10.1016/0042-6822(91)90621-h. [DOI] [PubMed] [Google Scholar]
  3. Blanck R. R., Ream N., Deegan M. J. Immunoglobulins in heroin users. Am J Epidemiol. 1980 Jan;111(1):81–86. doi: 10.1093/oxfordjournals.aje.a112877. [DOI] [PubMed] [Google Scholar]
  4. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495–503. doi: 10.1128/jcm.28.3.495-503.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown S. M., Stimmel B., Taub R. N., Kochwa S., Rosenfield R. E. Immunologic dysfunction in heroin addicts. Arch Intern Med. 1974 Dec;134(6):1001–1006. [PubMed] [Google Scholar]
  6. Chesebro B., Nishio J., Perryman S., Cann A., O'Brien W., Chen I. S., Wehrly K. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol. 1991 Nov;65(11):5782–5789. doi: 10.1128/jvi.65.11.5782-5789.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chesebro B., Wehrly K., Nishio J., Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol. 1992 Nov;66(11):6547–6554. doi: 10.1128/jvi.66.11.6547-6554.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De Wolf F., Hogervorst E., Goudsmit J., Fenyö E. M., Rübsamen-Waigmann H., Holmes H., Galvao-Castro B., Karita E., Wasi C., Sempala S. D. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1387–1400. doi: 10.1089/aid.1994.10.1387. [DOI] [PubMed] [Google Scholar]
  9. Delwart E. L., Sheppard H. W., Walker B. D., Goudsmit J., Mullins J. I. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol. 1994 Oct;68(10):6672–6683. doi: 10.1128/jvi.68.10.6672-6683.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Donahoe R. M., Nicholson J. K., Madden J. J., Donahoe F., Shafer D. A., Gordon D., Bokos P., Falek A. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin Immunol Immunopathol. 1986 Nov;41(2):254–264. doi: 10.1016/0090-1229(86)90109-1. [DOI] [PubMed] [Google Scholar]
  11. Duarte E. A., Clarke D. K., Moya A., Elena S. F., Domingo E., Holland J. Many-trillionfold amplification of single RNA virus particles fails to overcome the Muller's ratchet effect. J Virol. 1993 Jun;67(6):3620–3623. doi: 10.1128/jvi.67.6.3620-3623.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Higgins D. G. Sequence ordinations: a multivariate analysis approach to analysing large sequence data sets. Comput Appl Biosci. 1992 Feb;8(1):15–22. doi: 10.1093/bioinformatics/8.1.15. [DOI] [PubMed] [Google Scholar]
  13. Kimura M. Estimation of evolutionary distances between homologous nucleotide sequences. Proc Natl Acad Sci U S A. 1981 Jan;78(1):454–458. doi: 10.1073/pnas.78.1.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Korber B., Myers G. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses. 1992 Sep;8(9):1549–1560. doi: 10.1089/aid.1992.8.1549. [DOI] [PubMed] [Google Scholar]
  15. Kuiken C. L., Cornelissen M. T., Zorgdrager F., Hartman S., Gibbs A. J., Goudsmit J. Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution. J Gen Virol. 1996 Apr;77(Pt 4):783–792. doi: 10.1099/0022-1317-77-4-783. [DOI] [PubMed] [Google Scholar]
  16. Kuiken C. L., Goudsmit J. Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe. AIDS Res Hum Retroviruses. 1994 Mar;10(3):319–320. doi: 10.1089/aid.1994.10.319. [DOI] [PubMed] [Google Scholar]
  17. Kuiken C. L., Lukashov V. V., Baan E., Dekker J., Leunissen J. A., Goudsmit J. Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the amsterdam population. AIDS. 1996 Jan;10(1):31–37. doi: 10.1097/00002030-199601000-00005. [DOI] [PubMed] [Google Scholar]
  18. Kuiken C. L., Zwart G., Baan E., Coutinho R. A., van den Hoek J. A., Goudsmit J. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9061–9065. doi: 10.1073/pnas.90.19.9061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lukashov V. V., Kuiken C. L., Goudsmit J. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J Virol. 1995 Nov;69(11):6911–6916. doi: 10.1128/jvi.69.11.6911-6916.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lukashov V. V., Kuiken C. L., Vlahov D., Coutinho R. A., Goudsmit J. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. AIDS Res Hum Retroviruses. 1996 Aug 10;12(12):1179–1183. doi: 10.1089/aid.1996.12.1179. [DOI] [PubMed] [Google Scholar]
  21. McDonough R. J., Madden J. J., Falek A., Shafer D. A., Pline M., Gordon D., Bokos P., Kuehnle J. C., Mendelson J. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol. 1980 Dec;125(6):2539–2543. [PubMed] [Google Scholar]
  22. Mehrishi J. N., Mills I. H. Opiate receptors on lymphocytes and platelets in man. Clin Immunol Immunopathol. 1983 May;27(2):240–249. doi: 10.1016/0090-1229(83)90074-0. [DOI] [PubMed] [Google Scholar]
  23. Mientjes G. H., Miedema F., van Ameijden E. J., van den Hoek A. A., Schellekens P. T., Roos M. T., Coutinho R. A. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS. 1991 Jan;5(1):35–41. doi: 10.1097/00002030-199101000-00005. [DOI] [PubMed] [Google Scholar]
  24. Mientjes G. H., van Ameijden E. J., Weigel H. M., van den Hoek J. A., Coutinho R. A. Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers. BMJ. 1993 Feb 6;306(6874):371–373. doi: 10.1136/bmj.306.6874.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mientjes G. H., van Ameijden E. J., van den Hoek A. J., Goudsmit J., Miedema F., Coutinho R. A. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. AIDS. 1993 Oct;7(10):1363–1370. [PubMed] [Google Scholar]
  26. Muñoz A., Vlahov D., Solomon L., Margolick J. B., Bareta J. C., Cohn S., Astemborski J., Nelson K. E. Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr. 1992;5(7):694–700. [PubMed] [Google Scholar]
  27. Novella I. S., Duarte E. A., Elena S. F., Moya A., Domingo E., Holland J. J. Exponential increases of RNA virus fitness during large population transmissions. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5841–5844. doi: 10.1073/pnas.92.13.5841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Selwyn P. A., Alcabes P., Hartel D., Buono D., Schoenbaum E. E., Klein R. S., Davenny K., Friedland G. H. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med. 1992 Dec 10;327(24):1697–1703. doi: 10.1056/NEJM199212103272401. [DOI] [PubMed] [Google Scholar]
  29. Spijkerman I. J., Koot M., Prins M., Keet I. P., van den Hoek A. J., Miedema F., Coutinho R. A. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS. 1995 Sep;9(9):1085–1092. doi: 10.1097/00002030-199509000-00016. [DOI] [PubMed] [Google Scholar]
  30. Wetli C. V., Noto T. A., Fernandez-Carol A. Immunologic abnormalities in heroin addiction. South Med J. 1974 Feb;67(2):193–197. doi: 10.1097/00007611-197402000-00017. [DOI] [PubMed] [Google Scholar]
  31. Wolfs T. F., de Jong J. J., Van den Berg H., Tijnagel J. M., Krone W. J., Goudsmit J. Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9938–9942. doi: 10.1073/pnas.87.24.9938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wolinsky S. M., Korber B. T., Neumann A. U., Daniels M., Kunstman K. J., Whetsell A. J., Furtado M. R., Cao Y., Ho D. D., Safrit J. T. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science. 1996 Apr 26;272(5261):537–542. doi: 10.1126/science.272.5261.537. [DOI] [PubMed] [Google Scholar]
  33. Wybran J., Appelboom T., Famaey J. P., Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol. 1979 Sep;123(3):1068–1070. [PubMed] [Google Scholar]
  34. Zhu T., Mo H., Wang N., Nam D. S., Cao Y., Koup R. A., Ho D. D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 1993 Aug 27;261(5125):1179–1181. doi: 10.1126/science.8356453. [DOI] [PubMed] [Google Scholar]
  35. Zhu T., Wang N., Carr A., Nam D. S., Moor-Jankowski R., Cooper D. A., Ho D. D. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol. 1996 May;70(5):3098–3107. doi: 10.1128/jvi.70.5.3098-3107.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. van Gemen B., van Beuningen R., Nabbe A., van Strijp D., Jurriaans S., Lens P., Kievits T. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods. 1994 Sep;49(2):157–167. doi: 10.1016/0166-0934(94)90040-x. [DOI] [PubMed] [Google Scholar]
  37. van der Hoek L., Boom R., Goudsmit J., Snijders F., Sol C. J. Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum. J Clin Microbiol. 1995 Mar;33(3):581–588. doi: 10.1128/jcm.33.3.581-588.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. van der Hoek L., Sol C. J., Snijders F., Bartelsman J. F., Boom R., Goudsmit J. Human immunodeficiency virus type 1 RNA populations in faeces with higher homology to intestinal populations than to blood populations. J Gen Virol. 1996 Oct;77(Pt 10):2415–2425. doi: 10.1099/0022-1317-77-10-2415. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES